Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
---|
06/24/2004 | CA2507573A1 Nucleic acid labeling compounds |
06/24/2004 | CA2507156A1 Methods of therapy and diagnosis using targeting of cells that express lax |
06/24/2004 | CA2502015A1 5' cpg nucleic acids and methods of use |
06/23/2004 | EP1431390A1 Sample processing device and sample processing method |
06/23/2004 | EP1431312A1 Method for production and a composition for immobilising biological macromolecules in hydrogels and the use of said composition for producing biochips |
06/23/2004 | EP1431303A2 Composition for linear isothermal amplification of polynucleotide sequences |
06/23/2004 | EP1431298A1 Mannitol and glucitol derivatives |
06/23/2004 | EP1431297A1 Mannitol and glucitol derivatives |
06/23/2004 | EP1430157A2 RNA INTERFERENCE MEDIATED INHIBITION OF HEPATITIS C VIRUS (HCV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
06/23/2004 | EP1430152A2 Gene and protein relating to hepatocellular carcinoma |
06/23/2004 | EP1430147A1 Fluorescent quenching detection reagents and methods |
06/23/2004 | EP1430132A2 Methods of using 33751, a human potassium channel family member |
06/23/2004 | EP1430118A2 A gene encoding cyclododecanone monooxygenase |
06/23/2004 | EP1430072A2 Antisense modulation of cholesteryl ester transfer protein expression |
06/23/2004 | EP1430070A2 Novel clark protein and nucleic acid molecules and uses therefor |
06/23/2004 | EP1356115A4 Methods for detection of chloral hydrate in dichloroacetic acid |
06/23/2004 | EP1315410A4 Enhanced meristematic activity and competence by overexpression of tonoplast pyrophosphatase |
06/23/2004 | EP1180112A4 Detection using degradation of a tagged sequence |
06/23/2004 | EP0796346A4 Nucleic acid sequence detection employing amplification probes |
06/23/2004 | CN1506471A Nuclein detecting method |
06/23/2004 | CN1506467A SCAR marker linked with the acidic character of peach fruit and its application |
06/23/2004 | CN1154747C Means and methods for monitoring nucleoside reverse transcriptase inhibitor antiretrioviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS |
06/23/2004 | CN1154731C Gene of hop latent virus and methods for detecting the same |
06/23/2004 | CN1154729C Staphylokinase derivs |
06/23/2004 | CN1154727C Recombinant expression vector of human parathyroid hormone using phosphoribulokinase as fusion partner |
06/22/2004 | US6753423 For preferentially modulated gene expression in liver and associated tissues |
06/22/2004 | US6753309 Nucleosides for imaging and treatment applications |
06/22/2004 | US6752991 Nucleic acids encoding a house dust mite allergen Der p III, and uses therefor |
06/17/2004 | WO2004051218A2 Multiplex amplification of polynucleotides |
06/17/2004 | WO2004050900A2 Compositions, splice variants and methods relating to colon specific genes and proteins |
06/17/2004 | WO2004050899A2 Method for in vitro selection of 2’-substituted nucleic acids |
06/17/2004 | WO2004018497A3 Modified nucleotides for polynucleotide sequencing |
06/17/2004 | WO2003102138A3 Elongase genes and uses thereof |
06/17/2004 | WO2003058199A3 Arrays of microparticles and methods of preparation thereof |
06/17/2004 | US20040117869 Comprises nucleotide sequences coding oxidoreductase for use in increasing nornicotine biosynthesis in plants |
06/17/2004 | US20040116689 can comprise DNA, RNA, PNA, or any combination or chimera thereof |
06/17/2004 | US20040116687 oligonucleotides having reduced internucleotide charge and enhanced nuclease resistance |
06/17/2004 | US20040116685 Method for solution phase synthesis of oligonucleotides |
06/17/2004 | US20040116680 Photolabile protective groups for the synthesis of biopolymers |
06/17/2004 | US20040116667 Tyrosinase-related gene (TRP2) protein comprising human leukocyte antigen cytotoxic binding recognition points for identifying modulators for diagnosis, prevention and treatment of cancer ; immunotherapy |
06/17/2004 | US20040116366 Antisense modulation of protein phosphatase 2 catalytic subunit beta expression |
06/17/2004 | US20040116365 Modulation of Lck expression |
06/17/2004 | US20040115773 Serpin in bifidobacteria |
06/17/2004 | US20040115716 Identifying oligonucleotide subsequences associated with gene exprssion inhibition |
06/17/2004 | US20040115706 by detecting a fluorescent signal; for drug screening; solid phase synthesis |
06/17/2004 | US20040115696 Utilizing programmable functionalized self-assembling nucleic acids as building blocks for molecular electronic and photonic mechanisms, organizing interconnected nanostructures and/or micronized components of micro or optoelectronic devices |
06/17/2004 | US20040115694 Methods and compositions for determining the sequence of nucleic acid molecules |
06/17/2004 | US20040115693 Novel human kinase proteins and polynucleotides encoding the same |
06/17/2004 | US20040115691 Mutants of enzymes and methods for their use |
06/17/2004 | US20040115687 Comprise matrix polypeptide for diagnosis, treatment, and prevention of immunological, nervous system, developmental, connective tissue and cell proliferative disorders |
06/17/2004 | US20040115676 G-protein coupled receptors |
06/17/2004 | US20040115668 Human hyperpolarization-activated cyclic nucleotide-gated cation channel hcn3 |
06/17/2004 | US20040115665 Method for base sequencing and biologically active nucleic acids |
06/17/2004 | US20040115661 Shuttle vector for use as stable gene transfer tool in genetic engineering |
06/17/2004 | US20040115653 Modulation of endothelial lipase expression |
06/17/2004 | US20040115652 Antisense oligonucleotides for controlling expression of receptor tyrosine kinase gene and treatment of hyperproliferative disorders; gene expression inhibition |
06/17/2004 | US20040115651 Modulation of BUB3 expression |
06/17/2004 | US20040115650 Modulation of MAD1-like 1 expression |
06/17/2004 | US20040115649 Modulation of ABCC5 expression |
06/17/2004 | US20040115644 Identifying restriction fragment length polymorphisms via isothermal complexity reduction and nucleotide sequence amplification: genotyping and resequencing |
06/17/2004 | US20040115637 Antisense oligonucleotides for controlling expression of peroxisome proliferator-activated receptor alpha and treatment of hyperproliferative disorders; gene expression inhibition |
06/17/2004 | US20040115636 Modulation of interleukin 18 expression |
06/17/2004 | US20040115634 Antisense oligonucleotides for controlling expression of signal transducers and activators of transcription-6 (STAT-6) genes and treatment of autoimmune disorders; gene expression inhibition |
06/17/2004 | CA2506748A1 Method for in vitro selection of 2'-substituted nucleic acids |
06/16/2004 | EP1428892A1 Dual-purpose primers and probes for providing enhanced hybridization assays by disruption of secondary structure formation |
06/16/2004 | EP1428887A1 Replication-competent herpes simplex virus mediates destruction of neoplastic cells |
06/16/2004 | EP1428810A2 Libraries of oligomers labelled with different tags |
06/16/2004 | EP1427852A2 Single nucleotide amplification and detection by polymerase |
06/16/2004 | EP1427757A1 Late gestation lung genes, fragments and uses thereof |
06/16/2004 | EP1427750A1 Modified transferrin fusion proteins |
06/16/2004 | EP1427747A2 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
06/16/2004 | EP1427710A2 Method for the production of cna |
06/16/2004 | EP1119578B1 Improved process for oligonucleotide synthesis |
06/16/2004 | EP0672133B1 TNF-alpha RIBOZYMES AND DEGRADATION RESISTANT mRNA DERIVATIVES LINKED TO TNF-alpha RIBOZYMES |
06/16/2004 | CN1504481A Apoptosis promoting gene BNIPL, coding albumen and uses thereof |
06/16/2004 | CN1504477A Chicken polydactyly functional gene and uses thereof |
06/16/2004 | CN1504476A Polynucleotide for identifying polypeptide OT3 and coding OT3 of tumor cell and uses thereof |
06/16/2004 | CN1504475A Polynucleotide for identifying polypeptide OT10 and coding OT10 of tumor cell and uses thereof |
06/16/2004 | CN1153854C Ferro-nickel alloy electroplating process for copper plate working surface of continuously casting crystallizer |
06/15/2004 | US6750335 Nucleoside for use in the generation of preferential oligonuceotides |
06/15/2004 | US6750024 Nitro-substituted non-fluorescent asymmetric cyanine dye compounds |
06/15/2004 | US6750020 Method for alteration detection |
06/15/2004 | US6750019 Antisense modulation of insulin-like growth factor binding protein 5 expression |
06/15/2004 | US6750016 Nanoparticles having oligonucleotides attached thereto and uses therefor |
06/15/2004 | CA2285921C Composition and method for treatment of cmv infections |
06/10/2004 | WO2004049274A2 2’-0-trisubstituted silyloxymethyl-ribonucleoside-derivative and method for preparing the same |
06/10/2004 | WO2004048938A2 Methods of detecting soft tissue sarcoma, compositions and methods of screening for soft tissue sarcoma modulators |
06/10/2004 | WO2004048925A2 NaCT AS A TARGET FOR LIFESPAN EXPANSION AND WEIGHT REDUCTION |
06/10/2004 | WO2004048595A2 Vascular-preferred promoters |
06/10/2004 | WO2004048591A2 Methods for cohort selection and longevity studies |
06/10/2004 | WO2004048570A1 ENA NUCLEIC ACID DRUGS MODIFYING SPLICING IN mRNA PRECURSOR |
06/10/2004 | WO2004048564A1 Device for pretreating specimen |
06/10/2004 | WO2004048546A2 Methods for identifying risk of breast cancer and treatments thereof |
06/10/2004 | WO2004048524A2 Modulation of stat2 expression |
06/10/2004 | WO2004048522A2 Modulation of huntingtin interacting protein 2 expression |
06/10/2004 | WO2004048511A2 Bioinformatically detectable group of novel viral regulatory genes and uses thereof |
06/10/2004 | WO2004048451A2 Optical information carrier comprising immobilized proteorhodopsin |
06/10/2004 | WO2004048398A1 Method and apparatus for concentration and purification of nucleic acid |
06/10/2004 | WO2004048397A2 Detectable labeled nucleoside analogs and methods of use thereof |
06/10/2004 | WO2004048376A1 Bicyclic naphthylidine nucleosides |